The Business Group on Health is paying attention to Medicaid cuts, tariffs, threats to ERISA and more. There is no shortage ...

Given last year’s almost six billion dollars invested in AI-driven health-tech, the answer might seem to be “yes.” Well, not so fast. Optimists forecasting therapy-bots’ mental health ...

As hospitals brace for rising costs tied to President Donald Trump’s proposed tariffs, a new report from the American Hospital Association reveals that drugs and supplies are just part of the ...

Individual Coverage Health Reimbursement Arrangements, colloquially known as ICHRAs, have entered the zeitgeist. ICHRAs allow employers to provide employees a fixed amount of pre-tax money to ...

The numbers for first quarter 2025 biotech financings are in and they show a downturn in investments. A total of $6.5 billion was raised in the first quarter compared to $8.1 billion in the same ...

The Department of Justice has filed a complaint against Aetna, Elevance Health, Humana, eHealth, GoHealth, and SelectQuote, ...

Cytokinetics aims to compete with a Bristol Myers Squibb heart drug projected to become a blockbuster seller, and the company’s value proposition is that its drug candidate has a potential ...

In a healthcare landscape dominated by rising chronic condition rates and associated costs, artificial intelligence (AI) has emerged as a powerful tool for physicians seeking to integrate aspects ...

Businesses are struggling with the high cost of healthcare benefits for their employees. As companies prioritize their employees’ well-being, healthcare benefits are often their largest expense ...

Uncertainty dominates the healthcare spectrum, with the HHS led by the most anti-establishment head in modern times, Robert Kennedy Jr. It is sparking a lot of conversation about what the impact ...